Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPharming Group N.V. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2025 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 2 | -$0.00 | $0.01 | $0.00 |
| Q4 2025 | 2 | $0.00 | $0.03 | $0.02 |
| Q1 2026 | 1 | $0.03 | $0.03 | $0.03 |
| Q2 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q3 2026 | 1 | $0.01 | $0.01 | $0.01 |
| Q4 2026 | 1 | $0.01 | $0.01 | $0.01 |
Pharming Group N.V. Earnings Date And Information
Pharming Group N.V. last posted its earnings results on Thursday, November 6th, 2025. The company reported $0.1 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.05. The company had revenue of 97.29 M for the quarter and had revenue of 297.20 M for the year. Pharming Group N.V. has generated $0 earnings per share over the last year ($-0.17 diluted earnings per share) and currently has a price-to-earnings ratio of 3111.3. Pharming Group N.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based on prior year's report dates.
Pharming Group N.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | $0.05 | $0.11 | 0.06 | $98.22 M | $97.29 M |
| 07/31/2025 | Q2 2025 | -$0.10 | $0.07 | 0.17 | $82.63 M | $93.22 M |
| 05/08/2025 | Q1 2025 | -$0.25 | -$0.22 | 0.03 | N/A | $79.09 M |
| 04/03/2025 | Q4 2024 | N/A | $0.05 | N/A | N/A | $92.67 M |
| 09/29/2024 | Q3 2024 | N/A | -$0.02 | N/A | $76.93 M | $74.85 M |
| 06/28/2024 | Q2 2024 | N/A | -$0.01 | N/A | $71.94 M | $74.03 M |
| 03/29/2024 | Q1 2024 | N/A | -$0.15 | N/A | N/A | $55.59 M |
| 04/04/2024 | Q4 2023 | N/A | -$0.03 | N/A | N/A | $81.22 M |
| 09/30/2023 | Q3 2023 | N/A | $0.05 | N/A | $61.67 M | $66.66 M |
| 06/30/2023 | Q2 2023 | N/A | $0.02 | N/A | $53.23 M | $54.90 M |
| 03/31/2023 | Q1 2023 | N/A | -$0.15 | N/A | $50.34 M | $42.54 M |
| 04/05/2023 | Q4 2022 | N/A | -$0.18 | N/A | $60.25 M | $51.01 M |
| 09/29/2022 | Q3 2022 | N/A | $0.11 | N/A | $53.50 M | $55.35 M |
| 06/29/2022 | Q2 2022 | N/A | $0.18 | N/A | $51.99 M | $50.15 M |
| 03/30/2022 | Q1 2022 | N/A | $0.04 | N/A | $47.65 M | $46.62 M |
| 04/06/2022 | Q4 2021 | N/A | $0.02 | N/A | $57.58 M | $45.75 M |
| 06/30/2021 | Q2 2021 | N/A | $0.06 | N/A | $66.93 M | $42.58 M |
| 03/30/2021 | Q1 2021 | N/A | $0.10 | N/A | $61.29 M | $43.56 M |
| 04/07/2021 | Q4 2020 | N/A | $0.14 | N/A | $59.49 M | $70.23 M |
| 09/29/2020 | Q3 2020 | N/A | $0.10 | N/A | $55.09 M | $58.52 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pharming Group N.V. Earnings: FAQ's
Pharming Group N.V. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based offlast year's report dates.
In the previous quarter, Pharming Group N.V. (:PHAR) reported $0.1 earnings per share (EPS) to beat the analysts' consensus estimate of $0.05 by $0.05.
The conference call for Pharming Group N.V.'s latest earnings report can be listened to online.
The conference call transcript for Pharming Group N.V.'s latest earnings report can be read online.
Pharming Group N.V. (:PHAR) has a recorded annual revenue of $297.20 M.
Pharming Group N.V. (:PHAR) has a recorded net income of $-11,841,000.Pharming Group N.V. has generated $-0.17 earnings per share over the last four quarters.
Pharming Group N.V. (:PHAR) has a price-to-earnings ratio of 3111.3 and price/earnings-to-growth ratio is 229.46.